StepStone Group Inc. STEP Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001796022-25-000041
cik 1796022
name STEPSTONE GROUP INC.
sic 6282
countryba US
stprba NY
cityba NEW YORK
zipba 10172
bas1 277 PARK AVENUE
bas2 45TH FLOOR
baph 1-212-351-6100
countryma US
stprma NY
cityma NEW YORK
zipma 10172
mas1 277 PARK AVENUE
mas2 45TH FLOOR
countryinc
stprinc
ein 843868757
former
changed
afs 1-LAF
wksi 1
fye 0331
form 10-K
period 20250331
fy 2024
fp FY
filed 20250523
accepted 2025-05-23 16:06:00.0
prevrpt 0
detail 1
instance step-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001796022-25-000041 20250331 Accounts Payable Other Current And Noncurrent 331821000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 936000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A; Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -2743000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Stock Issued For Acquisitions 97383000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange -132560000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest -2881000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Assets 995188000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Assets 73311149000.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20250331 Assets 1376034000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Carried Interest Allocation And Investment Income Unrealized Gain Loss 127815000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20250331 Carried Interest Allocation And Investment Income Unrealized Gain Loss 148508000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20220331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 117449000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Common Stock Dividends Per Share Declared 1.0800 USD 4 us-gaap/2024
0001796022-25-000041 20250531 Common Stock Dividends Per Share Declared 0.4000 USD 0 us-gaap/2024 Class Of Stock= Common Class A; Dividends= S2026 Q1 Dividends; Subsequent Event Type= Subsequent Event;
0001796022-25-000041 20240331 Common Stock Shares Authorized 125000000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20250331 Common Stock Shares Authorized 650000000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20240331 Common Stock Shares Issued 45030959.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20240331 Common Stock Shares Outstanding 65614902.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20240331 Common Stock Shares Outstanding 45030959.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20240331 Common Stock Value 66000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20240331 Compensation Expense Cash Based Compensation And Benefits 292962000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest 79840000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 167145000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -171610000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Costs And Expenses 631707000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20250331 Costs And Expenses 901553000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Deferred Income Tax Assets Net 184512000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Deferred Income Tax Assets Net 349000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Deferred Tax Effect From Purchase Of Units Net 132560000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Disposal Group Not Discontinued Operation Gain Loss On Disposal 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Equity Method Investment Accrued Carried Interest Related Compensation Payable 758000000.0000 USD 0 0001796022-25-000041 Related Party Transactions By Related Party= Affiliated Entity;
0001796022-25-000041 20240331 Equity Method Investments Excluding Accrued Carried Interest Allocations 39590000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Gain Loss On Remeasurement Of Lease Liabilities 106000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Gain Loss On Remeasurement Of Lease Liabilities 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Income Tax Expense Benefit 28979000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Increase Decrease In Accounts Receivable 12349000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities 1988000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Increase Decrease In Other Operating Liabilities 566000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Intangible Assets Net Excluding Goodwill 304873000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Interest Paid Net 7237000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Investments 131858000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20240331 Legacy Investment Accrued Carried Interest Related Compensation Payable 484154000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Legacy Investments In Funds And Accrued Carried Interest Allocations 495700000.0000 USD 0 0001796022-25-000041 Related Party Transactions By Related Party= Affiliated Entity;
0001796022-25-000041 20240331 Liabilities 1915673000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Liabilities 2812321000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Liabilities 1278704000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Minority Interest 133489000.0000 USD 0 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 161250000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 79490000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Minority Interest Decrease From Redemptions 2249000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Net Cash Provided By Used In Financing Activities -57978000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Net Cash Provided By Used In Investing Activities -43475000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Net Cash Provided By Used In Operating Activities 151183000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Net Income Loss 58091000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 53731000.0000 USD 4 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20240331 Noncontrolling Interest Increase From Sale Of Parent Equity Interest 851000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Nonoperating Income Expense 44784000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Operating Lease Liability 17415000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Operating Lease Right Of Use Asset 97763000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Operating Lease Right Of Use Asset 16665000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Other Assets 1745000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Other Assets 62869000.0000 USD 0 us-gaap/2024 Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20230331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -181000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Other Comprehensive Income Loss Net Of Tax 235000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Other Comprehensive Income Loss Net Of Tax 424000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20240331 Other Liabilities 1645000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Other Liabilities 17580000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Partners Capital Account Contributions 3000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Payments For Repurchase Of Redeemable Noncontrolling Interest 18713000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Payments Of Dividends Common Stock 49973000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments Of Dividends Minority Interest 8989000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Payments Of Dividends Minority Interest 97341000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Payments To Acquire Equity Method Investments 21637000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20240331 Performance Fee Related Compensation Related To Carried Interest Allocation 112381000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Performance Fee Related Compensation Related To Carried Interest Allocation Realized 37687000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Proceeds From Capital Contributions From Non Controlling Interests 13387000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Proceeds From Capital Contributions From Non Controlling Interests 179000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Proceeds From Capital Contributions From Non Controlling Interests 12460000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Proceeds From Issuance Of Debt 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Proceeds From Long Term Lines Of Credit 50000000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Proceeds From Long Term Lines Of Credit 125000000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Proceeds From Minority Shareholders 62255000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Profit Loss -5310483000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 465339000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Redeemable Noncontrolling Interest Equity Carrying Amount 0.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Remeasurement Of Lease Liabilities 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Restricted Cash 718000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Retained Earnings Accumulated Deficit 13768000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Revenues -122253000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation;
0001796022-25-000041 20230331 Revenues -253342000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation Unrealized;
0001796022-25-000041 20240331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 5501000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 48000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 152658000.0000 USD 0 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 208514000.0000 USD 0 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Accounts Payable And Other Accrued Liabilities 89731000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Accounts Payable And Other Accrued Liabilities 27155000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Accounts Receivable Net 52566000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest -1000.0000 USD 4 0001796022-25-000041 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest -28893000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 816000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Amortization Of Financing Costs 847000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Carried Interest Allocation And Investment Income Unrealized Gain Loss -149293000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Cash And Cash Equivalents At Carrying Value 143430000.0000 USD 0 us-gaap/2024 Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20250331 Cash And Cash Equivalents At Carrying Value 75769000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20230331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 12068000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20250331 Common Stock Shares Outstanding 76761399.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20230331 Compensation Expense Cash Based Compensation And Benefits 252180000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest -19925000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20230331 Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 0.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Costs And Expenses 446413000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Costs And Expenses 539860000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Deferred Tax Effect From Purchase Of Units Net 5950000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Dividends Common Stock Cash 50787000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Dividends Common Stock Cash 76751000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20230331 Dividends Payable Current 814000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Dividends Payable Current 911000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Earnings Per Share Basic 0.9100 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Earnings Per Share Basic -2.5200 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Employee Related Liabilities Current And Noncurrent 101481000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Employee Related Liabilities Current And Noncurrent 736695000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 General And Administrative Expense 167317000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -222035000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Income Loss From Equity Method Investments -2509000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Due From Related Parties 30222000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Other Accounts Payable And Accrued Liabilities -1216000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Other Operating Assets 772000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Increase Decrease In Other Operating Liabilities 15975000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Interest Expense Nonoperating 9331000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Interest Paid Net 3551000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Investments 415011000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Investments 415011000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20240331 Minority Interest 147042000.0000 USD 0 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Minority Interest 1056510000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Minority Interest Decrease From Redemptions 5398000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Net Cash Provided By Used In Financing Activities 87481000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Net Income Loss Attributable To Noncontrolling Interest 59956000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20250331 Net Income Loss Attributable To Noncontrolling Interest -125850000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20240331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 5782000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 758000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -19772000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Other Comprehensive Income Loss Net Of Tax 1217000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 35194000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -227316000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Noncontrolling Interest Increase From Sale Of Parent Equity Interest 1553000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Operating Lease Liability 113519000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Operating Lease Right Of Use Asset 18307000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Other Assets 17688000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20230331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax 506000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Other Noncash Income Expense -40000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Other Receivables 47693000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001796022-25-000041 20230331 Partners Capital Account Contributions 37000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Partners Capital Account Contributions 142000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Partners Capital Account Contributions 43000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Partners Capital Account Contributions 8773000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Payment For Contingent Consideration Liability Operating Activities 51456000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments Of Dividends Minority Interest 129279000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Payments Related To Tax Withholding For Share Based Compensation 1472000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments To Acquire Equity Method Investments 12460000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Payments To Acquire Equity Method Investments 58613000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20230331 Payments To Acquire Property Plant And Equipment 5627000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments To Related Parties Tax Receivable Agreements 9819000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Performance Fee Related Compensation Related To Carried Interest Allocation Realized 94748000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Proceeds From Capital Contributions From Non Controlling Interests 8776000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 4412000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20250331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 15805000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20250331 Proceeds From Issuance Of Common Stock 2521000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Proceeds From Issuance Of Debt 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Proceeds From Payments For Other Financing Activities -5000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Proceeds From Sale Of Consolidated Funds 4000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Proceeds From Sale Of Consolidated Funds 2028000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Profit Loss -172827000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 451886000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 0.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Redeemable Noncontrolling Interest Equity Carrying Amount 24530000.0000 USD 0 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20240331 Redeemable Noncontrolling Interest Equity Carrying Amount 115920000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Repayments Of Lines Of Credit 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Restricted Cash 718000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Revenues 520258000.0000 USD 4 us-gaap/2024 Geographical= Non Us;
0001796022-25-000041 20250331 Revenues 653594000.0000 USD 4 us-gaap/2024 Geographical= Non Us;
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 32063000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 658000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1628787000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 636000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 728000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -242546000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20230331 Stock Issued During Period Value Conversion Of Convertible Securities -2000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20240331 Stock Issued During Period Value Conversion Of Convertible Securities 2000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -1472000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 1000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -897000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Employee Taxes 3000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Unrealized Investment Gain Loss From Consolidated Funds 9312000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Unrealized Investment Gain Loss From Consolidated Funds 62192000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Accounts Payable Other Current And Noncurrent 18072000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Additional Paid In Capital 421057000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 1000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 19546000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest -12666000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 41559000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Allocated Share Based Compensation Expense 42357000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Amortization Of Financing Costs 472000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Assets 4586693000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 9361000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Cash And Cash Equivalents At Carrying Value 102565000.0000 USD 0 us-gaap/2024 Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20230331 Common Stock Dividends Per Share Declared 0.8000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Common Stock Shares Issued 76761399.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20250331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest -1185000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Comprehensive Income Net Of Tax -179139000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Dividends Common Stock Cash 70346000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Employee Related Liabilities Current And Noncurrent 699015000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Equity Method Investments Accrued Carried Interest Allocations 1354051000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20230331 Income Loss From Consolidated Funds 9315000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Increase Decrease In Employee Related Liabilities 16458000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 16646000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Increase Decrease In Other Operating Assets 15943000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Investment Income Interest 1921000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Investment Income Interest 10850000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Legacy Investment Accrued Carried Interest Related Compensation Payable 495739000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Legacy Investments In Funds And Accrued Carried Interest Allocations 631197000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20240331 Liabilities 2083509000.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Minority Interest 208514000.0000 USD 0 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 39573000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 49789000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20230331 Net Cash Provided By Used In Financing Activities -108021000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Net Cash Provided By Used In Investing Activities -30807000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Net Cash Provided By Used In Investing Activities -47347000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Net Income Loss Attributable To Noncontrolling Interest -9087000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 1776000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Nonoperating Income Expense -32500000.0000 USD 4 us-gaap/2024 Counterparty Name= Private Wealth Funds;
0001796022-25-000041 20250331 Other Assets 16859000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20230331 Other Comprehensive Income Loss Net Of Tax -687000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Other Comprehensive Income Loss Net Of Tax -338000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Other Comprehensive Income Loss Net Of Tax -675000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Comprehensive Income Loss Net Of Tax -196000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20250331 Other Comprehensive Income Loss Net Of Tax 558000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Partners Capital Account Contributions 13387000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Partners Capital Account Contributions 12460000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Partners Capital Account Contributions 28379000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments Of Dividends Common Stock 68474000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments Of Dividends Minority Interest 11134000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Payments Related To Tax Withholding For Share Based Compensation 2743000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments To Minority Shareholders 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments To Minority Shareholders 5398000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Performance Fee Related Compensation Related To Carried Interest Allocation -39193000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 74694000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Proceeds From Payments For Other Financing Activities -1000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Proceeds From Sale Of Consolidated Funds 5199000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Profit Loss 167820000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Profit Loss 2592462000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Reclassifications Of Temporary To Permanent Equity 976354000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Reclassifications Of Temporary To Permanent Equity 976354000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Redeemable Noncontrolling Interest Increase From Redemption 97383000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Repayments Of Lines Of Credit 7912000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Revenues 497179000.0000 USD 4 us-gaap/2024 Product Or Service= Management And Advisory Fees Net;
0001796022-25-000041 20250331 Revenues 767014000.0000 USD 4 us-gaap/2024 Product Or Service= Management And Advisory Fees Net;
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 587243000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 668182000.0000 USD 0 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 461000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1654591000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Stock Issued During Period Value Conversion Of Convertible Securities 2000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stock Issued During Period Value Conversion Of Convertible Securities -8000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Stock Issued During Period Value Conversion Of Convertible Securities -10000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -1219000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -576000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stock Issued For Acquisitions 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Weighted Average Number Of Shares Outstanding Basic 61884671.0000 shares 4 us-gaap/2024
0001796022-25-000041 20240331 Accounts Payable Other Current And Noncurrent 5844000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Liabilities Step Stone Funds;
0001796022-25-000041 20250331 Accounts Payable Other Current And Noncurrent 0.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Liabilities Distributions Payable;
0001796022-25-000041 20240331 Accounts Receivable Net 56769000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange -5950000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange -5950000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 39000.0000 USD 4 0001796022-25-000041 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 21277000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10771000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Allocated Share Based Compensation Expense 24940000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Allocated Share Based Compensation Expense 651800000.0000 USD 4 us-gaap/2024 Award Type= Liability Classified Award;
0001796022-25-000041 20250331 Assets 91879641000.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Common Stock Dividends Per Share Declared 1.0800 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Common Stock Shares Authorized 125000000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20250331 Common Stock Shares Issued 39656954.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20250331 Common Stock Shares Outstanding 39656954.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20240331 Common Stock Value 45000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20250331 Common Stock Value 40000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class B;
0001796022-25-000041 20240331 Compensation And Benefits Expense 372543000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Compensation Expense Cash Based Compensation And Benefits 331808000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest -44075000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 758000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Deferred Income Tax Assets Net 382886000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Dividends Common Stock Cash 70346000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20230331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -287000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Remeasurement Of Lease Liabilities 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -3402000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Employee Related Liabilities Current And Noncurrent 57487000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Equity Method Investments Excluding Accrued Carried Interest Allocations 135043000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20250331 Equity Method Investments Excluding Accrued Carried Interest Allocations 176339000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001796022-25-000041 20240331 Goodwill 580542000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Income Taxes Paid 29487000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Increase Decrease In Due From Related Parties 24355000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Employee Related Liabilities 11160000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities 2006000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities -298000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 13151000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Other Operating Assets 3212000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20250331 Intangible Assets Net Excluding Goodwill 263872000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Investment Income Interest 3664000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Investments 131858000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20230331 Legacy Investment Income -44075000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Legacy Investment Income -1185000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Legacy Investments In Funds And Accrued Carried Interest Allocations 484200000.0000 USD 0 0001796022-25-000041 Related Party Transactions By Related Party= Affiliated Entity;
0001796022-25-000041 20240331 Liabilities 593701000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 11134000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 78439000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Net Income Loss Attributable To Noncontrolling Interest 37240000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Net Income Loss Attributable To Noncontrolling Interest 79282000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -47051000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -18398000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 146200000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Operating Lease Liability 18814000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Other Assets 11491000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20240331 Other Receivables 23986000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Other Receivables 65765000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Receivables Step Stone Funds;
0001796022-25-000041 20230331 Partners Capital Account Contributions 13566000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments Of Dividends Minority Interest 109509000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Payments Of Dividends Minority Interest 31971000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Repayments Of Long Term Lines Of Credit 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments Of Financing Costs 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments To Minority Shareholders 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized -119039000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized -134906000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Proceeds From Capital Contributions From Non Controlling Interests 19603000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 24035000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Proceeds From Issuance Of Common Stock 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Proceeds From Lines Of Credit 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Proceeds From Lines Of Credit 7872000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 134407000.0000 USD 4 0001796022-25-000041 Equity Components= Retained Earnings;
0001796022-25-000041 20250331 Reclassifications Of Temporary To Permanent Equity 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Redeemable Noncontrolling Interest Increase From Redemption 41504000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Restricted Cash 502000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Revenues 25339000.0000 USD 4 us-gaap/2024 Product Or Service= Incentive Fees;
0001796022-25-000041 20250331 Revenues 1174830000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Revenues 521236000.0000 USD 4 us-gaap/2024 Geographical= U S;
0001796022-25-000041 20250331 Revenues 159653000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation Realized;
0001796022-25-000041 20250331 Share Based Compensation 650132000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 63000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 610567000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 160430000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 45000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1390148000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 88876301000.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20240331 Stock Issued During Period Value Conversion Of Convertible Securities -1000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Stock Issued During Period Value Conversion Of Convertible Securities -2000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Stock Issued During Period Value Conversion Of Convertible Securities 10000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stock Issued During Period Value Conversion Of Convertible Securities -8000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20250331 Weighted Average Number Of Shares Outstanding Basic 71142916.0000 shares 4 us-gaap/2024
0001796022-25-000041 20240331 Accounts Payable And Other Accrued Liabilities 127417000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Accounts Payable Other Current And Noncurrent 18072000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Liabilities Step Stone Funds;
0001796022-25-000041 20250331 Accounts Receivable Net 66692000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax 728000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Additional Paid In Capital 310293000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest -18435000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 7112000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 8236000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 15776000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Carried Interest Allocation And Investment Income Unrealized Gain Loss -577484000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Cash And Cash Equivalents At Carrying Value 46859000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 289804000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Commitments And Contingencies USD 0 us-gaap/2024
0001796022-25-000041 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0001796022-25-000041 20240331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20230331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest 34856000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 1776000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20230331 Deferred Tax Effect From Purchase Of Units Net -3586000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Depreciation Depletion And Amortization 47443000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Depreciation Depletion And Amortization 47588000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Earnings Per Share Diluted 0.9100 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Equity Method Investment Accrued Carried Interest Related Compensation Payable 719500000.0000 USD 0 0001796022-25-000041 Related Party Transactions By Related Party= Affiliated Entity;
0001796022-25-000041 20240331 Equity Method Investments Excluding Accrued Carried Interest Allocations 135043000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001796022-25-000041 20250331 Equity Method Investments Excluding Accrued Carried Interest Allocations 183694000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20250331 General And Administrative Expense 177354000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Income Loss From Equity Method Investments 7452000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Due From Related Parties 15484000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Other Operating Liabilities 1079000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Interest Paid Net 8462000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Legacy Investment Income -9087000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Legacy Investments In Funds And Accrued Carried Interest Allocations 629228000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Legacy Performance Fee Related Compensation Related To Carried Interest Allocation -452163000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Legacy Performance Fee Related Compensation Related To Carried Interest Allocation -75157000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Liabilities And Stockholders Equity 4586693000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Revenues 141547000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation Unrealized;
0001796022-25-000041 20250331 Revenues 32275000.0000 USD 4 us-gaap/2024 Product Or Service= Incentive Fees;
0001796022-25-000041 20250331 Minority Interest 20793000.0000 USD 0 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20250331 Minority Interest 26465000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary Subsidiaries;
0001796022-25-000041 20230331 Net Income Loss Attributable To Noncontrolling Interest -44075000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 15838000.0000 USD 4 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20230331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -44075000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 59956000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 37240000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Noncontrolling Interest Increase From Sale Of Parent Equity Interest 3045000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 54977000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Nonoperating Income Expense -40957000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Other Comprehensive Income Loss Net Of Tax -153000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -118000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Liabilities 1645000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Other Liabilities 17580000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20240331 Other Nonoperating Income Expense 2455000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Other Receivables 12919000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Receivables Employees;
0001796022-25-000041 20250331 Other Receivables 14039000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Receivables Loans;
0001796022-25-000041 20250331 Partners Capital Account Contributions 19603000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Payment For Contingent Consideration Liability Operating Activities 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments For Repurchase Of Redeemable Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20250331 Payments For Repurchase Of Redeemable Noncontrolling Interest 12968000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20250331 Payments Of Dividends Common Stock 75840000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments To Acquire Consolidated Funds 21287000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Payments To Acquire Equity Method Investments 13387000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Payments To Acquire Equity Method Investments 23380000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20240331 Payments To Acquire Property Plant And Equipment 19607000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments To Acquire Property Plant And Equipment 5100000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments To Related Parties Tax Receivable Agreements 5981000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Performance Fee Related Compensation Related To Carried Interest Allocation Realized 79846000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized -119039000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20230331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 4563000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Proceeds From Issuance Of Common Stock 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Proceeds From Lines Of Credit 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Proceeds From Minority Shareholders 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20240331 Proceeds From Minority Shareholders 3045000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20250331 Proceeds From Minority Shareholders 240256000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Redeemable Noncontrolling Interest Increase From Redemption 55879000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Remeasurement Of Lease Liabilities -18166000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Repayments Of Long Term Lines Of Credit 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Restricted Cash 502000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Retained Earnings Accumulated Deficit -242546000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Revenues -238441000.0000 USD 4 us-gaap/2024 Geographical= U S;
0001796022-25-000041 20230331 Revenues -564753000.0000 USD 4 us-gaap/2024 Product Or Service= Performance Fees;
0001796022-25-000041 20250331 Revenues 74341000.0000 USD 4 us-gaap/2024 Product Or Service= Legacy Carried Interest Allocation;
0001796022-25-000041 20240331 Stockholders Equity 324476000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Stockholders Equity 179356000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 61000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 194480000.0000 USD 0 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 310293000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Stock Issued During Period Value Conversion Of Convertible Securities -1000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Stock Issued During Period Value Conversion Of Convertible Securities -1000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Stock Issued During Period Value Conversion Of Convertible Securities -1000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 1000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20250331 Accounts Payable And Other Accrued Liabilities 29484000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Accounts Payable Other Current And Noncurrent 206841000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Liabilities Non Controlling Interest Holders Due To Tax Receivable Agreements;
0001796022-25-000041 20250331 Accounts Payable Other Current And Noncurrent 313749000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Liabilities Non Controlling Interest Holders Due To Tax Receivable Agreements;
0001796022-25-000041 20250331 Accounts Receivable Net 80871000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax 304000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange -132560000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 8889000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 6659000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Allocated Share Based Compensation Expense 8600000.0000 USD 4 us-gaap/2024 Award Type= Liability Classified Award;
0001796022-25-000041 20240331 Assets 3788807000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Cash And Cash Equivalents At Carrying Value 38164000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Cash And Cash Equivalents At Carrying Value 44511000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Cash And Cash Equivalents At Carrying Value 244791000.0000 USD 0 us-gaap/2024 Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20230331 Compensation And Benefits Expense -214236000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest 59805000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20240331 Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 15838000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20240331 Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 5782000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Deferred Income Tax Assets Net 275000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Earnings Per Share Diluted -0.3000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Equity Method Investment Accrued Carried Interest Related Compensation Payable 719497000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20250331 Equity Method Investments Accrued Carried Interest Allocations 1495664000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20250331 Equity Method Investments Excluding Accrued Carried Interest Allocations 47362000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Gain Loss On Remeasurement Of Lease Liabilities 2709000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Income Tax Expense Benefit -49208000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Accounts Receivable 10309000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Increase Decrease In Due To Related Parties -765000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Due To Related Parties 815000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Increase Decrease In Due To Related Parties 11158000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Other Operating Assets 973000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Increase Decrease In Other Operating Assets -1024000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20250331 Interest Expense Nonoperating 12701000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Legacy Investment Accrued Carried Interest Related Compensation Payable 484154000.0000 USD 0 0001796022-25-000041 Reflects amounts attributable to consolidated VIEs for which the Company did not acquire any direct economic interests. See notes 2 and 5 for more information.
0001796022-25-000041 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 106330000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 31971000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Minority Interest Decrease From Redemptions 18713000.0000 USD 4 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20250331 Minority Interest Decrease From Redemptions 3149000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Net Cash Provided By Used In Operating Activities 161522000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Net Income Loss -179563000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 8436000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Nonoperating Income Expense 23625000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -793000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Other Noncash Income Expense -103000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Receivables 34744000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0001796022-25-000041 20240331 Partners Capital Account Contributions 12503000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payment For Contingent Consideration Liability Operating Activities 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments For Repurchase Of Redeemable Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20240331 Payments For Repurchase Of Redeemable Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Payments Of Financing Costs 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments To Acquire Equity Method Investments 19603000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Performance Fee Related Compensation Related To Carried Interest Allocation 189020000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 11211000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Proceeds From Capital Contributions From Non Controlling Interests 43000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Profit Loss 4516043000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20230331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Repayments Of Lines Of Credit 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Revenues 170867000.0000 USD 4 us-gaap/2024 Geographical= Non Us;
0001796022-25-000041 20240331 Revenues 176309000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation;
0001796022-25-000041 20240331 Revenues 49401000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation Realized;
0001796022-25-000041 20240331 Revenues 585140000.0000 USD 4 us-gaap/2024 Product Or Service= Management And Advisory Fees Net;
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1824330000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 229615000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 147042000.0000 USD 0 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 227000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 304000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 77000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 421057000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 2521000.0000 USD 4 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20240331 Unrealized Investment Gain Loss From Consolidated Funds 26147000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Weighted Average Number Of Diluted Shares Outstanding 61884671.0000 shares 4 us-gaap/2024
0001796022-25-000041 20240331 Weighted Average Number Of Diluted Shares Outstanding 66544038.0000 shares 4 us-gaap/2024
0001796022-25-000041 20250331 Weighted Average Number Of Diluted Shares Outstanding 71142916.0000 shares 4 us-gaap/2024
0001796022-25-000041 20240331 Accounts Payable Other Current And Noncurrent 212918000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Accounts Payable Other Current And Noncurrent 5845000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange 3586000.0000 USD 4 0001796022-25-000041 See notes 11 and 14 for more information.
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest -19546000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 388000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 19681000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 17322000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Allocated Share Based Compensation Expense 22900000.0000 USD 4 us-gaap/2024 Award Type= Liability Classified Award;
0001796022-25-000041 20240331 Amortization Of Financing Costs 472000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Cash And Cash Equivalents At Carrying Value 25997000.0000 USD 0 us-gaap/2024 Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Cash And Cash Equivalents At Carrying Value 44511000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20230331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 129517000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240531 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20240331 Common Stock Shares Issued 65614902.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20250331 Compensation And Benefits Expense 1264295000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest -9087000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20240331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest 36912000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest -125615000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20230331 Comprehensive Income Net Of Tax -18594000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -45962000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Costs And Expenses -67077000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Costs And Expenses 1441649000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Deferred Income Taxes And Tax Credits -75061000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Depreciation Depletion And Amortization 45489000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Disposal Group Not Discontinued Operation Gain Loss On Disposal -812000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Dividends Common Stock Cash 50787000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20250331 Dividends Common Stock Cash 76751000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Dividends Payable Current 1872000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Earnings Per Share Diluted -2.5200 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Goodwill 580542000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Income Loss From Consolidated Funds 65374000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 195396000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Income Taxes Paid 14145000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Income Tax Expense Benefit 27576000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Increase Decrease In Accounts Receivable 24102000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Increase Decrease In Employee Related Liabilities 3583000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Increase Decrease In Other Operating Assets -10705000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20230331 Interest Expense Nonoperating 4189000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Legacy Investments In Funds And Accrued Carried Interest Allocations 631197000.0000 USD 0 0001796022-25-000041 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Legacy Investments In Funds And Accrued Carried Interest Allocations 629228000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20240331 Liabilities And Stockholders Equity 3788807000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Long Term Debt 148822000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Minority Interest 974559000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Minority Interest 25362000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary Subsidiaries;
0001796022-25-000041 20230331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 31070000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 8989000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 57768000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Net Income Loss Attributable To Noncontrolling Interest 35194000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Net Income Loss Attributable To Noncontrolling Interest -1185000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 53731000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -9087000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 58091000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest 79282000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20230331 Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Assets 1745000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20240331 Other Assets 60611000.0000 USD 0 us-gaap/2024 Investment Type= Excluding Consolidated Funds;
0001796022-25-000041 20250331 Other Assets 17688000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 38000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Other Comprehensive Income Loss Net Of Tax -196000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001796022-25-000041 20240331 Other Comprehensive Income Loss Net Of Tax -328000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Other Noncash Income Expense -579000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Other Nonoperating Income Expense -1420000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Other Nonoperating Income Expense -32650000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Receivables 13450000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Receivables Employees;
0001796022-25-000041 20240331 Other Receivables 13493000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Receivables Loans;
0001796022-25-000041 20230331 Payment For Contingent Consideration Liability Financing Activities 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payment For Contingent Consideration Liability Financing Activities 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments For Proceeds From Other Investing Activities 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments For Proceeds From Other Investing Activities -1000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments Of Financing Costs 5401000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Payments To Acquire Consolidated Funds 77144000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized -526837000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 94272000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 5280000.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20250331 Proceeds From Issuance Of Debt 175000000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Proceeds From Minority Shareholders 22754000.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20250331 Proceeds From Minority Shareholders 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Variable Interest Entities V I E;
0001796022-25-000041 20240331 Proceeds From Payments For Other Financing Activities -1000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Profit Loss -45275000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 1086492000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 34860000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Reclassifications Of Temporary To Permanent Equity 976354000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Redeemable Noncontrolling Interest Equity Carrying Amount 102623000.0000 USD 0 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 6327000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20230331 Restricted Cash 955000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20230331 Revenues 131089000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation Realized;
0001796022-25-000041 20230331 Revenues 9663000.0000 USD 4 us-gaap/2024 Product Or Service= Incentive Fees;
0001796022-25-000041 20240331 Revenues 711631000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Revenues 407816000.0000 USD 4 us-gaap/2024 Product Or Service= Performance Fees;
0001796022-25-000041 20240331 Revenues 126908000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation Unrealized;
0001796022-25-000041 20230331 Share Based Compensation 24940000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Share Based Compensation 39448000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20220331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 780162000.0000 USD 0 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 974559000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 77000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 40000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 133489000.0000 USD 0 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 20793000.0000 USD 0 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1056510000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 92000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0001796022-25-000041 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 1585000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -304000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -392000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Accounts Payable Other Current And Noncurrent 233000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Liabilities Distributions Payable;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange 3586000.0000 USD 4 0001796022-25-000041 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20230331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 16389000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 674000.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 9847000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20250331 Allocated Share Based Compensation Expense 669126000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 16809000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Carried Interest Allocation And Investment Income Unrealized Gain Loss -261354000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20250331 Carried Interest Allocation And Investment Income Unrealized Gain Loss 2090000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20250331 Other Receivables 43830000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Cash And Cash Equivalents At Carrying Value 38164000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Investment Type= Consolidated Funds;
0001796022-25-000041 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 182312000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 52795000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 107492000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250531 Common Stock Dividends Per Share Declared 0.2400 USD 0 us-gaap/2024 Class Of Stock= Common Class A; Dividends= O2026 Q1 Dividends; Subsequent Event Type= Subsequent Event;
0001796022-25-000041 20240331 Common Stock Shares Authorized 650000000.0000 shares 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20250331 Common Stock Value 77000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A;
0001796022-25-000041 20250331 Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 53731000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20240331 Comprehensive Income Net Of Tax 57895000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Deferred Income Taxes And Tax Credits -12692000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Deferred Income Taxes And Tax Credits 9212000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Disposal Group Not Discontinued Operation Gain Loss On Disposal 0.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Earnings Per Share Basic -0.3000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -1442000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Equity Method Investment Accrued Carried Interest Related Compensation Payable 757968000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20230331 General And Administrative Expense 147159000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Income Loss From Consolidated Funds 28472000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20230331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -41454000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Income Loss From Equity Method Investments 15096000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Income Taxes Paid 14289000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Income Tax Expense Benefit 3821000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Income Tax Expense Benefit 12261000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20250331 Income Tax Expense Benefit 11644000.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20250331 Legacy Investment Accrued Carried Interest Related Compensation Payable 495739000.0000 USD 0 0001796022-25-000041
0001796022-25-000041 20250331 Legacy Performance Fee Related Compensation Related To Carried Interest Allocation 74341000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Liabilities 3003340000.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20250331 Long Term Debt 269268000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Minority Interest 147042000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary Legacy Entities;
0001796022-25-000041 20250331 Minority Interest 133489000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary Legacy Entities;
0001796022-25-000041 20230331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 120643000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Net Cash Provided By Used In Operating Activities 64928000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Net Income Loss -18398000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Net Income Loss Attributable To Noncontrolling Interest -19772000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary;
0001796022-25-000041 20230331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20240331 Net Income Loss Attributable To Redeemable Noncontrolling Interest 15838000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -1185000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -125850000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest -179563000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20240331 Noncontrolling Interest Increase From Sale Of Parent Equity Interest 641000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20250331 Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 54977000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Operating Lease Liability 119739000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Operating Lease Right Of Use Asset 91841000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Other Comprehensive Income Loss Net Of Tax -151000.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Of Subsidiary; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20250331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -1179000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Other Receivables 67531000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20240331 Other Receivables 40588000.0000 USD 0 us-gaap/2024 Related Party Transaction= Other Receivables Step Stone Funds;
0001796022-25-000041 20250331 Other Receivables 92723000.0000 USD 0 us-gaap/2024
0001796022-25-000041 20250331 Payment For Contingent Consideration Liability Financing Activities 17769000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments For Proceeds From Other Investing Activities -1000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Payments For Repurchase Of Redeemable Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001796022-25-000041 20240331 Payments Related To Tax Withholding For Share Based Compensation 695000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Payments To Acquire Consolidated Funds 226160000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Payments To Related Parties Tax Receivable Agreements 10281000.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 74694000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20250331 Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 94272000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Consolidated Entities Excluding Legacy Entities;
0001796022-25-000041 20240331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 3688000.0000 USD 4 us-gaap/2024 Consolidated Entities= Legacy Entities;
0001796022-25-000041 20230331 Proceeds From Long Term Lines Of Credit 35000000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20240331 Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 1086492000.0000 USD 4 0001796022-25-000041 Consolidated Entities= Subsidiaries;
0001796022-25-000041 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 377897000.0000 USD 0 us-gaap/2024 Consolidated Entities= Noncontrolling Interest In Consolidated Funds;
0001796022-25-000041 20250331 Repayments Of Long Term Lines Of Credit 175000000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Revenues -67574000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Revenues -452163000.0000 USD 4 us-gaap/2024 Product Or Service= Legacy Carried Interest Allocation;
0001796022-25-000041 20240331 Revenues 191373000.0000 USD 4 us-gaap/2024 Geographical= U S;
0001796022-25-000041 20240331 Revenues -75157000.0000 USD 4 us-gaap/2024 Product Or Service= Legacy Carried Interest Allocation;
0001796022-25-000041 20240331 Revenues 126491000.0000 USD 4 us-gaap/2024 Product Or Service= Performance Fees;
0001796022-25-000041 20250331 Revenues 301200000.0000 USD 4 us-gaap/2024 Product Or Service= Carried Interest Allocation;
0001796022-25-000041 20230331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 77347000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 46000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 36380000.0000 USD 0 us-gaap/2024 Consolidated Entities= Subsidiaries; Equity Components= Noncontrolling Interest;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 66000.0000 USD 0 us-gaap/2024 Class Of Stock= Common Class A; Equity Components= Common Stock;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 13768000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001796022-25-000041 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 71227640000.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001796022-25-000041 20230331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -1524000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001796022-25-000041 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -695000.0000 USD 4 us-gaap/2024
0001796022-25-000041 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Employee Taxes 3000.0000 USD 4 0001796022-25-000041 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001796022-25-000041 20230331 Stock Issued For Acquisitions 0.0000 USD 4 0001796022-25-000041
0001796022-25-000041 20240331 Weighted Average Number Of Shares Outstanding Basic 63489135.0000 shares 4 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Payments For Repurchase Of Redeemable Noncontrolling Interest us-gaap/2024 0 0 monetary D C Payments for Repurchase of Redeemable Noncontrolling Interest The cash outflow during the period for redemption of redeemable noncontrolling interests.
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Payments To Acquire Equity Method Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Equity Method Investments The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Payments Of Dividends Minority Interest us-gaap/2024 0 0 monetary D C Payments of Ordinary Dividends, Noncontrolling Interest Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.
Minority Interest Decrease From Redemptions us-gaap/2024 0 0 monetary D D Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Proceeds From Minority Shareholders us-gaap/2024 0 0 monetary D D Proceeds from Noncontrolling Interests Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.
Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2024 0 0 monetary D D Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Income Tax Assets Net us-gaap/2024 0 0 monetary I D Deferred Income Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Compensation And Benefits Expense 0001796022-25-000041 1 0 monetary D D Compensation And Benefits Expense Compensation And Benefits Expense
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Dividends Per Share Declared us-gaap/2024 0 0 perShare D Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Due To Related Parties us-gaap/2024 0 0 monetary D D Increase (Decrease) in Due to Related Parties The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Payment For Contingent Consideration Liability Operating Activities us-gaap/2024 0 0 monetary D C Payment for Contingent Consideration Liability, Operating Activities Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital us-gaap/2024 0 0 monetary D D Proceeds from Equity Method Investment, Distribution, Return of Capital Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Deferred Tax Effect From Purchase Of Units Net 0001796022-25-000041 1 0 monetary D D Deferred Tax Effect From Purchase Of Units, Net Deferred Tax Effect From Purchase Of Units, Net
Unrealized Investment Gain Loss From Consolidated Funds 0001796022-25-000041 1 0 monetary D C Unrealized Investment Gain (Loss) From Consolidated Funds Unrealized Investment Gain (Loss) From Consolidated Funds
Accounts Payable And Other Accrued Liabilities us-gaap/2024 0 0 monetary I C Accounts Payable and Other Accrued Liabilities Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.
Accounts Receivable Net us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Allocated Share Based Compensation Expense us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Disposal Group Not Discontinued Operation Gain Loss On Disposal us-gaap/2024 0 0 monetary D C Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.
Dividends Common Stock Cash us-gaap/2024 0 0 monetary D D Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Employee Related Liabilities Current And Noncurrent us-gaap/2024 0 0 monetary I C Employee-related Liabilities Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Income Taxes Paid us-gaap/2024 0 0 monetary D C Income Taxes Paid Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Long Term Debt us-gaap/2024 0 0 monetary I C Long-Term Debt Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.
Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 us-gaap/2024 0 0 monetary D D Noncash or Part Noncash Divestiture, Amount of Consideration Received Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Receivables us-gaap/2024 0 0 monetary I D Other Receivables Amount due from parties in nontrade transactions, classified as other.
Payments For Proceeds From Other Investing Activities us-gaap/2024 0 0 monetary D C Payments for (Proceeds from) Other Investing Activities Amount of cash (inflow) outflow from investing activities classified as other.
Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 0001796022-25-000041 1 0 monetary D D Comprehensive Income (Loss), Net Of Tax, Redeemable Noncontrolling Interest Comprehensive Income (Loss), Net Of Tax, Redeemable Noncontrolling Interest
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.
Increase Decrease In Other Operating Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Interest Expense Nonoperating us-gaap/2024 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Noncontrolling Interest Increase From Sale Of Parent Equity Interest us-gaap/2024 0 0 monetary D C Noncontrolling Interest, Increase from Sale of Parent Equity Interest Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.
Operating Lease Liability us-gaap/2024 0 0 monetary I C Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Payments To Minority Shareholders us-gaap/2024 0 0 monetary D C Payments to Noncontrolling Interests Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
Proceeds From Issuance Of Debt us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Debt The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.
Reclassifications Of Temporary To Permanent Equity us-gaap/2024 0 0 monetary D C Reclassifications of Temporary to Permanent Equity The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Payments To Related Parties Tax Receivable Agreements 0001796022-25-000041 1 0 monetary D C Payments To Related Parties, Tax Receivable Agreements Payments To Related Parties, Tax Receivable Agreements
Performance Fee Related Compensation Related To Carried Interest Allocation 0001796022-25-000041 1 0 monetary D D Performance Fee-Related Compensation Related to Carried Interest Allocation Performance Fee-Related Compensation Related to Carried Interest Allocation
Performance Fee Related Compensation Related To Carried Interest Allocation Realized 0001796022-25-000041 1 0 monetary D D Performance Fee-Related Compensation Related to Carried Interest Allocation, Realized Performance Fee-Related Compensation Related to Carried Interest Allocation, Realized
Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 0001796022-25-000041 1 0 monetary D D Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value
Dividends Payable Current us-gaap/2024 0 0 monetary I C Dividends Payable, Current Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Increase Decrease In Employee Related Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Increase Decrease In Other Operating Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Operating Liabilities Amount of increase (decrease) in operating liabilities classified as other.
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders us-gaap/2024 0 0 monetary D D Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Other Noncash Income Expense us-gaap/2024 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Compensation Expense Cash Based Compensation And Benefits 0001796022-25-000041 1 0 monetary D D Compensation Expense, Cash Based Compensation And Benefits Compensation Expense, Cash Based Compensation And Benefits
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Equity Method Investment Accrued Carried Interest Related Compensation Payable 0001796022-25-000041 1 0 monetary I C Equity Method Investment, Accrued Carried Interest Related Compensation Payable Equity Method Investment, Accrued Carried Interest Related Compensation Payable
Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 0001796022-25-000041 1 0 monetary D D Performance Fee-Related Compensation Related to Carried Interest Allocation, Unrealized Performance Fee-Related Compensation Related to Carried Interest Allocation, Unrealized
Remeasurement Of Lease Liabilities 0001796022-25-000041 1 0 monetary D C Remeasurement Of Lease Liabilities Remeasurement Of Lease Liabilities
Stock Issued For Acquisitions 0001796022-25-000041 1 0 monetary D C Stock Issued For Acquisitions Stock Issued For Acquisitions
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 us-gaap/2024 0 0 monetary D D Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.
Costs And Expenses us-gaap/2024 0 0 monetary D D Costs and Expenses Total costs of sales and operating expenses for the period.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Partners Capital Account Contributions us-gaap/2024 0 0 monetary D C Partners' Capital Account, Contributions Total contributions made by each class of partners (i.e., general, limited and preferred partners).
Proceeds From Long Term Lines Of Credit us-gaap/2024 0 0 monetary D D Proceeds from Long-Term Lines of Credit The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.
Proceeds From Payments For Other Financing Activities us-gaap/2024 0 0 monetary D D Proceeds from (Payments for) Other Financing Activities Amount of cash inflow (outflow) from financing activities classified as other.
Restricted Cash us-gaap/2024 0 0 monetary I D Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 0001796022-25-000041 1 0 monetary D C Noncontrolling Interest, Increase From Settlement Of Non-Controlling Interests Related To Awards Of Carried Interest Allocations Noncontrolling Interest, Increase From Settlement Of Non-Controlling Interests Related To Awards Of Carried Interest Allocations
Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Employee Taxes 0001796022-25-000041 1 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Net of Shares Withheld For Employee Taxes Stock Issued During Period, Value, Restricted Stock Award, Net of Shares Withheld For Employee Taxes
Accounts Payable Other Current And Noncurrent us-gaap/2024 0 0 monetary I C Accounts Payable, Other Amount of obligations incurred and payable classified as other.
Legacy Investments In Funds And Accrued Carried Interest Allocations 0001796022-25-000041 1 0 monetary I D Legacy Investments In Funds And Accrued Carried Interest Allocations Legacy Investments In Funds And Accrued Carried Interest Allocations
Amortization Of Financing Costs us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax us-gaap/2024 0 0 monetary D D Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.
Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2024 0 0 monetary I C Redeemable Noncontrolling Interest, Equity, Carrying Amount As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange 0001796022-25-000041 1 0 monetary D D Adjustments To Additional Paid In Capital, Deferred Tax Effect Of Exchange Adjustments To Additional Paid In Capital, Deferred Tax Effect Of Exchange
Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 0001796022-25-000041 1 0 monetary D C Adjustments To Additional Paid In Capital, Reallocation Of Noncontrolling Interest Adjustments To Additional Paid In Capital, Reallocation Of Noncontrolling Interest
Equity Method Investments Accrued Carried Interest Allocations 0001796022-25-000041 1 0 monetary I D Equity Method Investments, Accrued Carried Interest Allocations Equity Method Investments, Accrued Carried Interest Allocations
Gain Loss On Remeasurement Of Lease Liabilities 0001796022-25-000041 1 0 monetary D C Gain (Loss) On Remeasurement Of Lease Liabilities Gain (Loss) On Remeasurement Of Lease Liabilities
Income Loss From Consolidated Funds 0001796022-25-000041 1 0 monetary D C Income (Loss) From Consolidated Funds Income (Loss) From Consolidated Funds
Proceeds From Capital Contributions From Non Controlling Interests 0001796022-25-000041 1 0 monetary D D Proceeds From Capital Contributions From Non-Controlling Interests Proceeds From Capital Contributions From Non-Controlling Interests
Redeemable Noncontrolling Interest Increase From Redemption 0001796022-25-000041 1 0 monetary D C Redeemable Noncontrolling Interest, Increase From Redemption Redeemable Noncontrolling Interest, Increase From Redemption
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Other Liabilities us-gaap/2024 0 0 monetary I C Other Liabilities Amount of liabilities classified as other.
Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 0 0 monetary D C Payment, Tax Withholding, Share-Based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Proceeds From Lines Of Credit us-gaap/2024 0 0 monetary D D Proceeds from Lines of Credit Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
Carried Interest Allocation And Investment Income Unrealized Gain Loss 0001796022-25-000041 1 0 monetary D C Carried Interest Allocation And Investment Income, Unrealized Gain (Loss) Carried Interest Allocation And Investment Income, Unrealized Gain (Loss)
Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest 0001796022-25-000041 1 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Nonredeemable Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Nonredeemable Noncontrolling Interest
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Deferred Income Taxes And Tax Credits us-gaap/2024 0 0 monetary D D Deferred Income Taxes and Tax Credits Amount of deferred income tax expense (benefit) and income tax credits.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Due From Related Parties us-gaap/2024 0 0 monetary D C Increase (Decrease) in Due from Related Parties The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Payment For Contingent Consideration Liability Financing Activities us-gaap/2024 0 0 monetary D C Payment for Contingent Consideration Liability, Financing Activities Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.
Payments Of Financing Costs us-gaap/2024 0 0 monetary D C Payments of Financing Costs The cash outflow for loan and debt issuance costs.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Repayments Of Lines Of Credit us-gaap/2024 0 0 monetary D C Repayments of Lines of Credit Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
Equity Method Investments Excluding Accrued Carried Interest Allocations 0001796022-25-000041 1 0 monetary I D Equity Method Investments, Excluding Accrued Carried Interest Allocations Equity Method Investments, Excluding Accrued Carried Interest Allocations
Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities 0001796022-25-000041 1 0 monetary D D Increase (Decrease) In Lease Right Of Use Assets, Net Of Lease Liabilities Increase (Decrease) In Lease Right Of Use Assets, Net Of Lease Liabilities
Legacy Investment Accrued Carried Interest Related Compensation Payable 0001796022-25-000041 1 0 monetary I C Legacy Investment, Accrued Carried Interest Related Compensation Payable Legacy Investment, Accrued Carried Interest Related Compensation Payable
Legacy Investment Income 0001796022-25-000041 1 0 monetary D C Legacy Investment Income Legacy Investment Income
Proceeds From Sale Of Consolidated Funds 0001796022-25-000041 1 0 monetary D D Proceeds From Sale of Consolidated Funds Proceeds From Sale of Consolidated Funds
Legacy Performance Fee Related Compensation Related To Carried Interest Allocation 0001796022-25-000041 1 0 monetary D D Legacy Performance Fee-Related Compensation Related to Carried Interest Allocation Legacy Performance Fee-Related Compensation Related to Carried Interest Allocation
Investments us-gaap/2024 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Minority Interest us-gaap/2024 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Net Income Loss Attributable To Redeemable Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.
Other Assets us-gaap/2024 0 0 monetary I D Other Assets Amount of assets classified as other.
Payments Of Dividends Common Stock us-gaap/2024 0 0 monetary D C Payments of Ordinary Dividends, Common Stock Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
Repayments Of Long Term Lines Of Credit us-gaap/2024 0 0 monetary D C Repayments of Long-Term Lines of Credit The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Payments To Acquire Consolidated Funds 0001796022-25-000041 1 0 monetary D C Payments To Acquire Consolidated Funds Payments To Acquire Consolidated Funds

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001796022-25-000041 3 48 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001796022-25-000041 3 49 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings (accumulated deficit) 0
0001796022-25-000041 3 19 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001796022-25-000041 3 20 BS 0 H Restricted Cash us-gaap/2024 Restricted cash 0
0001796022-25-000041 3 21 BS 0 H Accounts Receivable Net us-gaap/2024 Fees and accounts receivable 0
0001796022-25-000041 3 22 BS 0 H Other Receivables us-gaap/2024 Due from affiliates 0
0001796022-25-000041 3 24 BS 0 H Equity Method Investments Excluding Accrued Carried Interest Allocations 0001796022-25-000041 Investments in funds 0
0001796022-25-000041 3 25 BS 0 H Equity Method Investments Accrued Carried Interest Allocations 0001796022-25-000041 Accrued carried interest allocations 0
0001796022-25-000041 3 26 BS 0 H Legacy Investments In Funds And Accrued Carried Interest Allocations 0001796022-25-000041 Legacy Greenspring investments in funds and accrued carried interest allocations 0
0001796022-25-000041 3 27 BS 0 H Deferred Income Tax Assets Net us-gaap/2024 Deferred income tax assets 0
0001796022-25-000041 3 28 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Lease right-of-use assets, net 0
0001796022-25-000041 3 29 BS 0 H Other Assets us-gaap/2024 Other assets and receivables 0
0001796022-25-000041 3 30 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Intangibles, net 0
0001796022-25-000041 3 31 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0001796022-25-000041 3 32 BS 0 H Investments us-gaap/2024 Investments, at fair value 0
0001796022-25-000041 3 33 BS 0 H Assets us-gaap/2024 Total assets 0
0001796022-25-000041 3 35 BS 0 H Accounts Payable And Other Accrued Liabilities us-gaap/2024 Accounts payable, accrued expenses and other liabilities 0
0001796022-25-000041 3 36 BS 0 H Employee Related Liabilities Current And Noncurrent us-gaap/2024 Accrued compensation and benefits 0
0001796022-25-000041 3 37 BS 0 H Equity Method Investment Accrued Carried Interest Related Compensation Payable 0001796022-25-000041 Accrued carried interest-related compensation 0
0001796022-25-000041 3 38 BS 0 H Legacy Investment Accrued Carried Interest Related Compensation Payable 0001796022-25-000041 Legacy Greenspring accrued carried interest-related compensation 0
0001796022-25-000041 3 39 BS 0 H Accounts Payable Other Current And Noncurrent us-gaap/2024 Due to affiliates 0
0001796022-25-000041 3 40 BS 0 H Operating Lease Liability us-gaap/2024 Lease liabilities 0
0001796022-25-000041 3 41 BS 0 H Long Term Debt us-gaap/2024 Debt obligations 0
0001796022-25-000041 3 42 BS 0 H Other Liabilities us-gaap/2024 Other liabilities 0
0001796022-25-000041 3 43 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001796022-25-000041 3 44 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 15) 0
0001796022-25-000041 3 45 BS 0 H Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2024 Redeemable non-controlling interests in Consolidated Funds 0
0001796022-25-000041 3 47 BS 0 H Common Stock Value us-gaap/2024 Common stock 0
0001796022-25-000041 3 50 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income 0
0001796022-25-000041 3 51 BS 0 H Stockholders Equity us-gaap/2024 Total StepStone Group Inc. stockholders equity 0
0001796022-25-000041 3 52 BS 0 H Minority Interest us-gaap/2024 Non-controlling interests 0
0001796022-25-000041 3 53 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total stockholders equity 0
0001796022-25-000041 3 54 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders equity 0
0001796022-25-000041 4 7 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001796022-25-000041 4 8 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0001796022-25-000041 4 9 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued (in shares) 0
0001796022-25-000041 4 10 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding (in shares) 0
0001796022-25-000041 5 19 IS 0 H Revenues us-gaap/2024 Total revenues 0
0001796022-25-000041 5 22 IS 0 H Compensation Expense Cash Based Compensation And Benefits 0001796022-25-000041 Cash-based compensation 0
0001796022-25-000041 5 23 IS 0 H Allocated Share Based Compensation Expense us-gaap/2024 Equity-based compensation 0
0001796022-25-000041 5 25 IS 0 H Performance Fee Related Compensation Related To Carried Interest Allocation Realized 0001796022-25-000041 Realized 0
0001796022-25-000041 5 26 IS 0 H Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 0001796022-25-000041 Unrealized 0
0001796022-25-000041 5 27 IS 0 H Performance Fee Related Compensation Related To Carried Interest Allocation 0001796022-25-000041 Total performance fee-related compensation 0
0001796022-25-000041 5 28 IS 0 H Legacy Performance Fee Related Compensation Related To Carried Interest Allocation 0001796022-25-000041 Legacy Greenspring performance fee-related compensation 0
0001796022-25-000041 5 29 IS 0 H Compensation And Benefits Expense 0001796022-25-000041 Total compensation and benefits 0
0001796022-25-000041 5 30 IS 0 H General And Administrative Expense us-gaap/2024 General, administrative and other 0
0001796022-25-000041 5 31 IS 0 H Costs And Expenses us-gaap/2024 Total expenses 0
0001796022-25-000041 5 33 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 Investment income (loss) 0
0001796022-25-000041 5 34 IS 0 H Legacy Investment Income 0001796022-25-000041 Legacy Greenspring investment loss 0
0001796022-25-000041 5 35 IS 0 H Income Loss From Consolidated Funds 0001796022-25-000041 Investment income of Consolidated Funds 0
0001796022-25-000041 5 36 IS 0 H Investment Income Interest us-gaap/2024 Interest income 0
0001796022-25-000041 5 37 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense 1
0001796022-25-000041 5 38 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (loss) 0
0001796022-25-000041 5 39 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expense) 0
0001796022-25-000041 5 40 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income (loss) before income tax 0
0001796022-25-000041 5 41 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax expense (benefit) 0
0001796022-25-000041 5 42 IS 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001796022-25-000041 5 43 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Less: Net income attributable to non-controlling interests 0
0001796022-25-000041 5 44 IS 0 H Net Income Loss Attributable To Redeemable Noncontrolling Interest us-gaap/2024 Less: Net income attributable to redeemable non-controlling interests 0
0001796022-25-000041 5 45 IS 0 H Net Income Loss us-gaap/2024 Net income (loss) attributable to StepStone Group Inc. 0
0001796022-25-000041 5 47 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic (in dollars per share) 0
0001796022-25-000041 5 48 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted (in dollars per share) 0
0001796022-25-000041 5 50 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic (in shares) 0
0001796022-25-000041 5 51 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Diluted (in shares) 0
0001796022-25-000041 5 52 IS 0 H Common Stock Dividends Per Share Declared us-gaap/2024 Dividends declared per share of Class A common stock (in dollars per share) 0
0001796022-25-000041 6 9 CI 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001796022-25-000041 6 11 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0001796022-25-000041 6 12 CI 0 H Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax us-gaap/2024 Unrealized gain (loss) on defined benefit plan, net 1
0001796022-25-000041 6 13 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Total other comprehensive income (loss) 0
0001796022-25-000041 6 14 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Comprehensive income (loss) before non-controlling interests 0
0001796022-25-000041 6 15 CI 0 H Comprehensive Income Loss Net Of Tax Attributable To Nonredeemable Noncontrolling Interest 0001796022-25-000041 Less: Comprehensive income (loss) attributable to non-controlling interests 0
0001796022-25-000041 6 16 CI 0 H Comprehensive Income Loss Net Of Tax Redeemable Noncontrolling Interest 0001796022-25-000041 Less: Comprehensive income attributable to redeemable non-controlling interests 0
0001796022-25-000041 6 17 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income (loss) attributable to StepStone Group Inc. 0
0001796022-25-000041 7 20 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total stockholders' equity, beginning balance 0
0001796022-25-000041 7 21 EQ 0 H Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest us-gaap/2024 Net income (loss) 0
0001796022-25-000041 7 22 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income (loss) 0
0001796022-25-000041 7 23 EQ 0 H Partners Capital Account Contributions us-gaap/2024 Contributed capital 0
0001796022-25-000041 7 24 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Equity-based compensation 0
0001796022-25-000041 7 25 EQ 0 H Minority Interest Decrease From Distributions To Noncontrolling Interest Holders us-gaap/2024 Distributions 1
0001796022-25-000041 7 26 EQ 0 H Dividends Common Stock Cash us-gaap/2024 Dividends declared 1
0001796022-25-000041 7 27 EQ 0 H Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2024 Vesting of RSUs, net of shares withheld for employee taxes 0
0001796022-25-000041 7 28 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Exchange of units 0
0001796022-25-000041 7 29 EQ 0 H Noncontrolling Interest Increase From Sale Of Parent Equity Interest us-gaap/2024 Sale of non-controlling interests 0
0001796022-25-000041 7 30 EQ 0 H Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2024 Class A common stock issued under ESPP 0
0001796022-25-000041 7 31 EQ 0 H Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Employee Taxes 0001796022-25-000041 Vesting of Class B2 units and issuance of corresponding Class B common stock at par value 0
0001796022-25-000041 7 32 EQ 0 H Minority Interest Decrease From Redemptions us-gaap/2024 Purchase of non-controlling interests 1
0001796022-25-000041 7 33 EQ 0 H Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 0001796022-25-000041 Settlement of non-controlling interests related to awards of carried interest allocations 0
0001796022-25-000041 7 34 EQ 0 H Redeemable Noncontrolling Interest Increase From Redemption 0001796022-25-000041 Redemption of redeemable non-controlling interests in subsidiaries 0
0001796022-25-000041 7 35 EQ 0 H Adjustments To Additional Paid In Capital Reallocation Of Noncontrolling Interest 0001796022-25-000041 Equity reallocation between controlling and non-controlling interests 0
0001796022-25-000041 7 36 EQ 0 H Adjustments To Additional Paid In Capital Deferred Tax Effect Of Exchange 0001796022-25-000041 Deferred tax effect resulting from equity transactions affecting ownership in the Partnership 1
0001796022-25-000041 7 37 EQ 0 H Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 0001796022-25-000041 Reclassification and adjustment of non-controlling interests in subsidiaries to redeemable equity at redemption value 1
0001796022-25-000041 7 38 EQ 0 H Reclassifications Of Temporary To Permanent Equity us-gaap/2024 Reclassification of non-controlling interests in subsidiaries from redeemable equity 0
0001796022-25-000041 7 39 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total stockholders' equity, ending balance 0
0001796022-25-000041 8 15 CF 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001796022-25-000041 8 17 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001796022-25-000041 8 18 CF 0 H Carried Interest Allocation And Investment Income Unrealized Gain Loss 0001796022-25-000041 Unrealized carried interest allocations and investment (income) loss 1
0001796022-25-000041 8 19 CF 0 H Performance Fee Related Compensation Related To Carried Interest Allocation Unrealized 0001796022-25-000041 Unrealized performance fee-related compensation 0
0001796022-25-000041 8 20 CF 0 H Amortization Of Financing Costs us-gaap/2024 Amortization of deferred financing costs 0
0001796022-25-000041 8 21 CF 0 H Share Based Compensation us-gaap/2024 Equity-based compensation 0
0001796022-25-000041 8 22 CF 0 H Deferred Income Taxes And Tax Credits us-gaap/2024 Change in deferred income taxes 0
0001796022-25-000041 8 23 CF 0 H Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 us-gaap/2024 Fair value adjustment for acquisition-related contingent consideration 0
0001796022-25-000041 8 24 CF 0 H Gain Loss On Remeasurement Of Lease Liabilities 0001796022-25-000041 Gain on remeasurement of lease liabilities 1
0001796022-25-000041 8 25 CF 0 H Disposal Group Not Discontinued Operation Gain Loss On Disposal us-gaap/2024 Loss on sale of subsidiary 1
0001796022-25-000041 8 26 CF 0 H Payment For Contingent Consideration Liability Operating Activities us-gaap/2024 Payments for acquisition-related contingent consideration 1
0001796022-25-000041 8 27 CF 0 H Other Noncash Income Expense us-gaap/2024 Other non-cash activities 1
0001796022-25-000041 8 29 CF 0 H Unrealized Investment Gain Loss From Consolidated Funds 0001796022-25-000041 Unrealized investment income of Consolidated Funds 1
0001796022-25-000041 8 30 CF 0 H Payments To Acquire Consolidated Funds 0001796022-25-000041 Purchases of investments of Consolidated Funds 1
0001796022-25-000041 8 31 CF 0 H Proceeds From Sale Of Consolidated Funds 0001796022-25-000041 Proceeds from sale of investments of Consolidated Funds 0
0001796022-25-000041 8 33 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Fees and accounts receivable 1
0001796022-25-000041 8 34 CF 0 H Increase Decrease In Due From Related Parties us-gaap/2024 Due from affiliates 1
0001796022-25-000041 8 35 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2024 Other assets and receivables 1
0001796022-25-000041 8 36 CF 0 H Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable, accrued expenses and other liabilities 0
0001796022-25-000041 8 37 CF 0 H Increase Decrease In Employee Related Liabilities us-gaap/2024 Accrued compensation and benefits 0
0001796022-25-000041 8 38 CF 0 H Increase Decrease In Due To Related Parties us-gaap/2024 Due to affiliates 0
0001796022-25-000041 8 39 CF 0 H Increase Decrease In Lease Right Of Use Assets Net Of Lease Liabilities 0001796022-25-000041 Lease right-of-use assets, net and lease liabilities 0
0001796022-25-000041 8 41 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2024 Other assets and receivables 1
0001796022-25-000041 8 42 CF 0 H Increase Decrease In Other Operating Liabilities us-gaap/2024 Other liabilities and payables 0
0001796022-25-000041 8 43 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by operating activities 0
0001796022-25-000041 8 45 CF 0 H Payments To Acquire Equity Method Investments us-gaap/2024 Contributions to investments 1
0001796022-25-000041 8 46 CF 0 H Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital us-gaap/2024 Distributions received from investments 0
0001796022-25-000041 8 47 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0001796022-25-000041 8 48 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2024 Other investing activities 1
0001796022-25-000041 8 49 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001796022-25-000041 8 51 CF 0 H Proceeds From Capital Contributions From Non Controlling Interests 0001796022-25-000041 Proceeds from capital contributions 0
0001796022-25-000041 8 52 CF 0 H Payments To Minority Shareholders us-gaap/2024 Purchase of non-controlling interests 1
0001796022-25-000041 8 53 CF 0 H Payments For Repurchase Of Redeemable Noncontrolling Interest us-gaap/2024 Redemption of redeemable non-controlling interests 1
0001796022-25-000041 8 54 CF 0 H Proceeds From Minority Shareholders us-gaap/2024 Proceeds from sale of non-controlling interests 0
0001796022-25-000041 8 55 CF 0 H Proceeds From Long Term Lines Of Credit us-gaap/2024 Proceeds from revolving credit facility 0
0001796022-25-000041 8 56 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of Class A common stock of shares under ESPP 0
0001796022-25-000041 8 57 CF 0 H Proceeds From Issuance Of Debt us-gaap/2024 Proceeds from issuance of notes payable 0
0001796022-25-000041 8 58 CF 0 H Payments Of Financing Costs us-gaap/2024 Deferred financing costs 1
0001796022-25-000041 8 59 CF 0 H Repayments Of Long Term Lines Of Credit us-gaap/2024 Payments on revolving credit facility 1
0001796022-25-000041 8 60 CF 0 H Payments Of Dividends Minority Interest us-gaap/2024 Distributions to non-controlling interests 1
0001796022-25-000041 8 61 CF 0 H Payment For Contingent Consideration Liability Financing Activities us-gaap/2024 Payments for acquisition-related contingent consideration 1
0001796022-25-000041 8 62 CF 0 H Payments Of Dividends Common Stock us-gaap/2024 Dividends paid to common stockholders 1
0001796022-25-000041 8 63 CF 0 H Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 Payments for employee taxes related to net settlement of RSUs 1
0001796022-25-000041 8 64 CF 0 H Payments To Related Parties Tax Receivable Agreements 0001796022-25-000041 Payments to related parties under Tax Receivable Agreements 1
0001796022-25-000041 8 65 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2024 Other financing activities 0
0001796022-25-000041 8 67 CF 0 H Proceeds From Lines Of Credit us-gaap/2024 Proceeds from borrowings on fund credit facility 0
0001796022-25-000041 8 68 CF 0 H Repayments Of Lines Of Credit us-gaap/2024 Payments on fund credit facility 1
0001796022-25-000041 8 69 CF 0 H Proceeds From Minority Shareholders us-gaap/2024 Contributions from redeemable non-controlling interests in Consolidated Funds 0
0001796022-25-000041 8 70 CF 0 H Payments For Repurchase Of Redeemable Noncontrolling Interest us-gaap/2024 Redemptions of redeemable non-controlling interests in Consolidated Funds 1
0001796022-25-000041 8 71 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by (used in) financing activities 0
0001796022-25-000041 8 72 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of foreign currency exchange rate changes 0
0001796022-25-000041 8 73 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase in cash, cash equivalents and restricted cash 0
0001796022-25-000041 8 74 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash at beginning of period 0
0001796022-25-000041 8 75 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash at end of period 0
0001796022-25-000041 8 77 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001796022-25-000041 8 78 CF 0 H Income Taxes Paid us-gaap/2024 Taxes paid 0
0001796022-25-000041 8 80 CF 0 H Dividends Payable Current us-gaap/2024 Accrued dividends 0
0001796022-25-000041 8 81 CF 0 H Deferred Tax Effect From Purchase Of Units Net 0001796022-25-000041 Deferred tax effect resulting from transactions affecting ownership in the Partnership, including net amounts payable under Tax Receivable Agreements 0
0001796022-25-000041 8 82 CF 0 H Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2024 Establishment of lease liabilities in exchange for lease right-of-use assets 0
0001796022-25-000041 8 83 CF 0 H Remeasurement Of Lease Liabilities 0001796022-25-000041 Remeasurement of lease liabilities 0
0001796022-25-000041 8 84 CF 0 H Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 us-gaap/2024 Issuance of note related to sale of subsidiary 0
0001796022-25-000041 8 85 CF 0 H Reclassifications Of Permanent Equity To Temporary Equity And Adjustment To Redemption Value 0001796022-25-000041 Reclassification and adjustment of non-controlling interests in subsidiaries to redeemable equity at redemption value 0
0001796022-25-000041 8 86 CF 0 H Noncontrolling Interest Increase From Settlement Of Non Controlling Interests Related To Awards Of Carried Interest Allocations 0001796022-25-000041 Settlement of non-controlling interests related to awards of carried interest allocations 0
0001796022-25-000041 8 87 CF 0 H Stock Issued For Acquisitions 0001796022-25-000041 Equity issued for redemption of redeemable non-controlling interests 0
0001796022-25-000041 8 89 CF 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001796022-25-000041 8 90 CF 0 H Restricted Cash us-gaap/2024 Restricted cash 0
0001796022-25-000041 8 91 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Total cash, cash equivalents and restricted cash 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.